Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-11-16
1994-04-19
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
A61K 4902
Patent
active
053043677
ABSTRACT:
A composition useful as an imaging agent comprises a beta adrenergic receptor antagonist compound, preferably iodopindolol, to which is covalently attached an iodine radioisotope such as .sup.123 I or .sup.124 I. This composition is used in a method for radioimaging beta adrenergic receptors in a tissue, preferably brain. In particular, the method is useful with the radioimaging technique of single photon emission computed tomography (SPECT) or positron emission tomography (PET). The above composition, as well as a kit comprising a set of one or more standard radiographic images of beta adrenergic receptors, are also useful in methods for (1) diagnosing an alteration in beta adrenergic receptors in a tissue, particularly brain; (2) diagnosing suicidal depression in a subject; and (3) detecting the therapeutic normalization of beta adrenergic receptor expression in a subject.
REFERENCES:
patent: 4311685 (1982-01-01), Snyder
patent: 4970238 (1990-11-01), Louis et al.
Weinberger, D. R. et al., Adv. Neurol. 51:147-150 (1990).
Antoni, G. et al., Appl. Radiat. Isot. 40:561-564 (1989) (Int. J. Radiat. Appl. Instrum. Part A).
Wagner, H. N., Jr., In: Quantitative Receptor Autoradiography, Boast, C. A. et al., eds., Alan R. Liss, Inc., 1986, pp. 233-254).
Hughes, B. et al., Nuc. Med. Biol. 13:565-71 (1986).
Hughes, B. et al., J. Nucl. Med. 27:66-667 (1986).
Tondo, L. et al., J. Pharmacol. Exp. Ther. 235:1-1 (1985).
Conway, P. G. et al. J. Pharmacol. Exp. Ther. 241:755-62 (1987).
Rainbow, T. C. et al., J. Neurosci. Meth. 5:127-138 (1982).
Rainbow, T. C. et al. Proc. Natl. Acad. Sci. USA 81:1585-89 (1984).
Kuhar, M. J. In: Quantitative Receptor Autoradiography, Boast, C. A. et al., eds., Alan R. Liss, Inc., 1986, pp. 1-12.
Mann, J. J. et al., Arch. Gen. Psychiat. 43:954-959 (1986).
Biegon, A. et al., Brain Res. 442:199-203 (1988).
Garvey, H. L. et al. J. Pharmacol. Exp. Ther. 194:220-233 (1975).
Arendt, R. M. et al. Cardiology 71:307-314 (1984).
Arnett, C. D. et al. J. Neurochem. 44:835 (1985).
Arnett, C. D. et al., J. Nucl. Med. 27:1878 (1986).
Kinsey, B. et al. Abstract for Soc. Nucl. Medicine 38th Ann. Meeting, Jun. 11-14, (1991).
Tewson, T. J. et al. (abstract 7) and Kinsey, B. M. et al., abstract (source known).
Tewson, T. J. et al., Paper from 1986 Radio-pharmaceutical Chemistry Meeting, Boston, pp. 388-90.
Moretti-Rojas et al, "Serotonergic and Adrenergic Regulation . . . ," J. Biol. Chem, vol. 258, No. 20, Oct. 25, 1983, pp. 12499-12508.
Hughes et al, "Characterization of Beta-Adrenoreceptors . . . ", J. Nucl Med, vol. 27(5), 1986, pp. 660-667.
Covert John M.
New York University
Stoll Robert L.
LandOfFree
In vivo brain imaging agent and method for diagnosis of psychiat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vivo brain imaging agent and method for diagnosis of psychiat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo brain imaging agent and method for diagnosis of psychiat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-18427